N-(2-chlorophenyl)-2-nitrobenzamide, 250mg

1-(2-(Piperidin-1-yl)phenyl)ethan-1-ol, 95+%, 5g

tert-butyl N-[(1S,2S)-1-[methoxy(methyl)carbamoyl]-2-methylbutyl]carbamate, 95.0%, 10g

4-(Trifluoromethoxy)benzoyl acetonitrile, 97.0%, 250mg

(S)-5-tert-Butyl 1-methyl 2-aminopentanedioate, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-cyanopropanoic acid, 95.0%, 5g

3-Chloro-N-(4-trifluoromethoxy-phenyl)-propionamide, 99.0%, 5g

1-chloro-9H-thioxanthen-9-one, 98%, 5g

4-Chloro-3-fluorobenzamide, 95.0%, 10g

Ethyl (S)-(+)-3-Piperidinecarboxylate>98.0%(GC)(T)25g

3-Fluoro-2-methylphenylisothiocyanate, 97.0%, 25g

N-bromosuccinimide, min 98%, per sintesi, 100 g, confezione in vetro

4-Amino-3-fluoropyridine, 97.0%, 1g